TrialVascular health and risk management2009

Selective endothelin A-receptor blockade attenuates coronary microvascular dysfunction after coronary stenting in patients with type 2 diabetes.

Nikolaos Ostlund Papadogeorgos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.